An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy

Clinical Infectious Diseases

Volumn 53, Issue 9, 2011, Pages 952-960

  Koethe, John R ^a   Jenkins, Cathy A ^b   Shepherd, Bryan E ^b   Stinnette, Samuel E ^a   Sterling, Timothy R ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Biostatistics ^*  (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION; IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; TENNESSEE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 80054059676     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir606     Document Type: Article

References (40)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-38. (Pubitemid 36459468)
2. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298:2028-37. (Pubitemid 350074800)
3. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162:1867-72.
4. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 2000; 23:81-8. (Pubitemid 30123269)
5. Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr 2001; 26:291-7. (Pubitemid 32246560)
6. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 2003; 37(Suppl 2):S69-80. (Pubitemid 37102727)
7. Paton NI, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med 2006; 7:323-30. (Pubitemid 43805693)
8. Koethe JR, Limbada MI, Giganti MJ, et al. Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia. AIDS 2010; 24:2117-21.
9. Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 2008; 22:873-82. (Pubitemid 351563837)
10. Barth RE, van der Meer JT, Hoepelman AI, et al. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis 2008; 27:977-84.
11. Tedaldi EM, Brooks JT, Weidle PJ, et al. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 2006; 43:35-41. (Pubitemid 44306485)
12. Crum-Cianflone NF, Roediger M, Eberly LE, et al. Obesity among HIVinfected persons: impact of weight on CD4 cell count. AIDS 2010; 24:1069-72.
13. National Heart, Lung, and Blood Institute (NHLBI). The evidence report: clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health (NIH) publication 98-4083Bethesda, MD: NHLBI, 1998.
14. Wang Y, Beydoun MA. The obesity epidemic in the United States: gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29:6-28. (Pubitemid 47229643)
15. Amorosa V, Synnestvedt M, Gross R, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005; 39:557-61. (Pubitemid 41098470)
16. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 2008; 22:925-30.
17. Greenfield JR, Samaras K, Jenkins AB, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004; 109:3022-8. (Pubitemid 38808325)
18. Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 2007; 4:e115.
19. Thewissen MM, Damoiseaux JG, Duijvestijn AM, et al. Abdominal fat mass is associated with adaptive immune activation: the CODAM study. Obesity (Silver Spring) 2011; 19:1690-98.
20. Chandra RK. 1990 McCollum Award lecture. Nutrition and immunity: lessons from the past and new insights into the future. Am J Clin Nutr 1991; 53:1087-101.
21. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
22. Little RJA, Rubin DB. Statistical analysis with missing data. Hoboken, NJ: Wiley, 1987.
23. Keusch G. Malnutrition and the thymus gland. In Cunningham-Rundles S, ed: Nutrient modulation of the immune response. New York, NY: Marcel Dekker., 1993; 283-99.
24. Gershwin M, Beach R, Hurley L. Nutrition and immunity. New York, NY: Academic Press, 1984.
25. Najera O, Gonzalez C, Cortes E, Toledo G, Ortiz R. Effector T lymphocytes in well-nourished and malnourished infected children. Clin Exp Immunol 2007; 148:501-6. (Pubitemid 46701032)
26. McMurray DN. Cellular immune changes in undernourished children. Prog Clin Biol Res 1981; 67:305-18.
27. Benito JM, Lopez M, Lozano S, et al. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD41 T cells under successful highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2005; 38:373-81. (Pubitemid 40381546)
28. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD41 T cell gains in human immunodeficiency virusinfected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-43. (Pubitemid 36578959)
29. Srinivasula S, Lempicki RA, Adelsberger JW, et al. Differential effects of HIV viral load and CD4 counts on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 2011; 118:262-70.
30. Melekhin VV, Shepherd BE, Stinnette SE, et al. Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response. PLoS One 2009; 4:e6961.
31. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 2006; 118:58-65.
32. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD41CD251and FOXP31 regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007; 178:2572-8. (Pubitemid 46233460)
33. Greenblatt RM, Ameli N, Grant RM, Bacchetti P, Taylor RN. Impact of the ovulatory cycle on virologic and immunologic markers in HIVinfected women. J Infect Dis 2000; 181:82-90. (Pubitemid 30049036)
34. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000; 199:15-24. (Pubitemid 30118591)
35. Sanchez-Margalet V, Martin-Romero C, Santos-Alvarez J, Goberna R, Najib S, Gonzalez-Yanes C. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 2003; 133:11-9. (Pubitemid 36791936)
36. Fezeu L, Julia C, Henegar A, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011; 12:653-59.
37. Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52:301-12.
38. Huttunen R, Laine J, Lumio J, Vuento R, Syrjanen J. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect Dis 2007; 7:13.
39. Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. A timedependent analysis of intensive care unit pneumonia in trauma patients. J Trauma 2004; 56:296-301; discussion 301-3.
40. Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents: guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 10 January 2011.